Johnson & Johnson (NYSE:JNJ) today shared details on its surgical robotic platform that it says offers unrivaled flexibility and control compared to the rest of the market. The new system is designed with six arms to provide more control and flexibility in surgery, while its arms will be integrated into the operating table. Additionally, the platform […]
Oncology
Novocure closes $575M offering
NovoCure (NSDQ:NVCR) announced that it closed its previously announced offering of $575 million in 0% convertible senior notes. The notes, due in 2025, are set to bring in net proceeds of approximately $558.4 million after the initial purchasers exercised full their option to purchase an additional $75 million in notes, according to a news release from […]
Exact Sciences to acquire Thrive for $2.15B
Exact Sciences (NSDQ:EXAS) announced today that it is acquiring cancer detection tech developer Thrive Earlier Detection for $2.15 billion. Under the agreement, Thrive will receive the total consideration of up to $2.15 billion, which includes $1.7 billion payable at closing, comprised of 65% of Exact Sciences common stock and 35% in cash, according to a […]
GE Healthcare debuts breast cancer tech
GE Healthcare (NYSE:GE) announced today that it made the Serena Bright biopsy technology available in the U.S. Chicago-based GE Healthcare touts Serena Bright as the industry’s first contrast-enhanced guided biopsy solution, according to a news release. The technology is designed to help clinicians and patients in the fight against breast cancer. Serena Bright received FDA 510(k) […]
Varian shareholders approve Siemens’ takeover
Varian Medical Systems (NYSE:VAR) announced today that its stockholders approved the pending combination with Siemens Healthineers (ETR:SHL). Stockholders from the Palo Alto, Calif.-based cancer care technology developer voted overwhelmingly in favor of the transaction at a special meeting, according to a news release. In August, the companies announced that Siemens would acquire Varian in a $16.4 […]
Smiths Medical, bioAffinity partner on cancer diagnostic
BioAffinity Technologies and Smiths Medical announced today that they are partnering to improve care with at-home collection of sputum. San Antonio-based BioAffinity’s CyPath Lung, a non-invasive flow cytometry diagnostic test for lung cancer, is set to be used in the partnership to analyze the at-home collection of sputum, according to a news release. Patients are […]
The top 10 medical disruptors of 2021
For the past 18 years, the Cleveland Clinic has predicted what the top 10 medical disruptors will be for the following year. The list of technologies, cultivated by a panel of physicians and scientists at the clinic, was led by Dr. Will Morris, executive medical director of Cleveland Clinic Innovations, and Dr. Akhil Saklecha, managing […]
Delcath names new CEO
Delcath Systems (OTC:DCTH) announced that it appointed Gerard Michel as its new CEO, effective yesterday, Oct. 1, 2020. Michel assumed the role yesterday and also was appointed as a Class I director on the company’s board of directors, with that role continuing until the expiry of his term at the company’s 2022 annual meeting of stockholders, […]
GE Healthcare kicks off AI in imaging project in France
GE Healthcare (NYSE:GE) announced that it launched its AI DReAM project for facilitating artificial intelligence use in medical imaging. The consortium is slated to gather French companies, research labs and clinical centers to aid in the development of AI in the imaging space. With €13 million in funding from the “Investments for the Future” program led […]
Coloplast invests $4M in Francis Medical
Urological cancer treatment developer Francis Medical announced today that it received a $4 million equity investment from Coloplast (CPH:COLO-B). Minneapolis-based Francis Medical develops ablation technology designed to apply thermal energy stored in sterile water vapor to deliver targeted treatments to the cancerous tissue in a transurethral procedure, according to a news release. The procedure potentially minimizes […]
TriSalus names new chief medical officer
TriSalus today said it appointed Steven Katz as chief medical officer. Katz will be responsible for overseeing the company’s clinical development strategy in the treatment of solid tumors. He has served as TriSalus’s chief medical advisor and chairperson of its scientific advisory board since 2018. “We are thrilled to have Steven join TriSalus as a […]
